Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 3.2 million shares were traded. NOV stock price reached its highest trading level at $15.12 during the session, while it also had its lowest trading level at $14.83.
Ratios:
For a deeper understanding of NOV Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.34.
On March 24, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $22. Evercore ISI Downgraded its Outperform to In-line on January 15, 2025, whereas the target price for the stock was revised from $25 to $18.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 21 ’25 when Kendall Christian S bought 70,000 shares for $14.46 per share. The transaction valued at 1,012,200 led to the insider holds 85,949 shares of the business.
CHRISTY NOVAK bought 21,435 shares of NOV for $316,078 on Nov 24 ’25. On Nov 24 ’25, another insider, CHRISTY NOVAK, who serves as the Officer of the company, bought 450 shares for $15.04 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NOV now has a Market Capitalization of 5581612032 and an Enterprise Value of 6687235584. As of this moment, NOV’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.01, and their Forward P/E ratio for the next fiscal year is 13.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.62 while its Price-to-Book (P/B) ratio in mrq is 0.85. Its current Enterprise Value per Revenue stands at 0.762 whereas that against EBITDA is 6.074.
Stock Price History:
The Beta on a monthly basis for NOV is 0.97, which has changed by -0.060037494 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, NOV has reached a high of $16.55, while it has fallen to a 52-week low of $10.65. The 50-Day Moving Average of the stock is 7.33%, while the 200-Day Moving Average is calculated to be 12.66%.
Shares Statistics:
For the past three months, NOV has traded an average of 4.13M shares per day and 4886070 over the past ten days. A total of 366.51M shares are outstanding, with a floating share count of 361.72M. Insiders hold about 0.83% of the company’s shares, while institutions hold 106.22% stake in the company. Shares short for NOV as of 1763078400 were 24058388 with a Short Ratio of 6.49, compared to 1760486400 on 28636076. Therefore, it implies a Short% of Shares Outstanding of 24058388 and a Short% of Float of 14.89.
Dividends & Splits
According to the company, the forward annual dividend rate for NOV is 0.30, from 0.3 in the trailing year. Against a Trailing Annual Dividend Yield of 0.019960081. The stock’s 5-year Average Dividend Yield is 1.25. . The current Payout Ratio is 17.15% for NOV, which recently paid a dividend on 2025-09-12 with an ex-dividend date of 2025-12-05. Stock splits for the company last occurred on 2014-06-02 when the company split stock in a 1109:1000 ratio.
